Bioactive Compounds and Diabetes Mellitus: Prospects and Future Challenges
The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Abstract
Diabetes mellitus is a metabolic condition that influences the endocrine framework. Hyperglycemia and hyperlipidemia are two of the most widely recognized metabolic irregularities in diabetes and two of the most well-known reasons for diabetic intricacies. Diabetes mellitus is a persistent illness brought about by metabolic irregularities in hyperglycemic pancreatic cells. Hyperglycemia can be brought about by an absence of insulin-producing beta cells in the pancreas (Type 1 diabetes mellitus) or inadequate insulin creation that does not work effectively (Type 2 diabetes mellitus). Present diabetes medication directs blood glucose levels in the systemic circulation to the typical levels. Numerous advanced prescription medicines have many negative results that can bring about unexpected severe issues during treatment of the bioactive compound from a different source that is beneficially affected by controlling and adjusting metabolic pathways or cycles. Moreover, a few new bioactive medications disengaged from plants have shown antidiabetic action with more noteworthy adequacy than the oral hypoglycemic agent that specialists have utilized in clinical treatment lately. Since bioactive mixtures are collected from familiar sources, they have a great activity in controlling diabetes mellitus. This study discusses bioactive compounds, their activity in managing diabetes mellitus, and their prospects. Though bioactive compounds have many health-beneficial properties, adequate clinical studies still need to acknowledge that they effectively manage diabetes mellitus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The growing body of evidence linking the regular intake of bioactives to the reduction in risk factors for chronic non-communicable diseases, such as cardiovascular disease, type 2 diabetes, metabolic syndrome, cancer, and neurodegenerative disorders, has led to a surge in interest around functional foods, which are designed to deliver health benefits beyond basic nutrition [2,3].”
From Microalgae Bioactives for Functional Food Innovation and Health Promotion (2025) · cites this paper as [3]
Citations
Cites
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
Type 2 diabetes: principles of pathogenesis and therapy
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525
Hennekens, C. H., Buring, J. E., Manson, J. E., Stampfer, M., Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341801 · Cited by 2,397
Flavonoids--Chemistry, metabolism, cardioprotective effects, and dietary sources
Cook, N. (1996) · The Journal of Nutritional Biochemistry · doi:10.1016/0955-2863(95)00168-9 · Cited by 2,364
McIntyre, H. D., Catalano, P., Zhang, C., Desoye, G., Mathiesen, E. R., & Damm, P. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0098-8 · Cited by 1,850
Medicinal plants of India with anti-diabetic potential
Grover, J. K., Yadav, S., & Vats, V. (2002) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(02)00059-4 · Cited by 1,798
Bantle (2008) · doi:10.2337/dc08-s061 · Cited by 1,795
Functional food. Product development, marketing and consumer acceptance—a review
Siró, I., Kápolna, E., Kápolna, B., & Lugasi, A. (2008) · Appetite · doi:10.1016/j.appet.2008.05.060 · Cited by 1,758
Research works printed but not linked: 29
- Bhoyar P.K.; Tripathi A.K.; Baheti J.R.; Herbal antidiabetics: A review. Int J Res Pharm Sci 2011,2(1),30-37
- Galal E.E.; Gawad M.A.; Antidiabetic activity of Egyptian onion “Allium cepa” extract. J Egypt Med Assoc 1965,48(Suppl.),14-45
- Kumari K.; Augusti K.T.; Antidiabetic and antioxidant effects of S-methyl cysteine sulfoxide isolated from onions (Allium cepa linn) as compared to standard drugs in alloxan diabetic rats. Indian J Exp Biol 2002,40(9),1005-1009
- Das S.; Garlic - a natural source of cancer preventive compounds. Asian Pac J Cancer Prev 2002,3(4),305-311
- Gupta R.; Gupta R.; Effect of Pterocarpus marsupium in streptozotocin-induced hyperglycemic state in rats: Comparison with glibenclamide. Diabetol Croat 2009,38(2),39-45
- Chakravarthy B.K.; Saroj G.; Gambhir S.S.; Pancreatic beta cell regeneration – a novel antidiabetic mechanism of Pterocarpus marsupium roxb. Indian J Pharmacol 1980,12(2),123
- Noipha K.; Ratanachaiyavong S.; Purintrapiban J.; Herunsaleed A.; Ninla-aesong P.; Effect of Tinospora crispa on glucose uptake in skeletal muscle: Role of glucose transporter 1 expression and extracellular signal-regulated kinase1/2 activation. Asian Biomed 2011,5(3),361-369
- Klangjareonchai T.; Roongpisuthipong C.; The effect of Tinospora crispa on serum glucose and insulin levels in patients with type 2 diabetes mellitus. BioMed Res Int 2012,2012,808762
- Sathya S.; Kokilavani R.; Gurusamy K.; Hypoglycemic effect of Gymnema sylvestre (retz.,) R.Br leaf in normal and alloxan induced diabetic rats. Anc Sci Life 2008,28(2),12-14
- Maslov D.L.; Ipatova O.M.; Abakumova O.Iu.; Tsvetkova T.A.; Prozorovskiĭ V.N.; Hypoglycemic effect of an extract from Aronia melanocarpa leaves. Vopr Med Khim 2002,48(3),271-277
- Bhutkar M.A.; Bhise S.B.; In vitro assay of alpha amylase inhibitory activity of some indigenous plants. Int J Chem Sci 2012,10(1),457-462
- Sidhu AK; Wani SJ; Tamboli PS; In vitro evaluation of anti-diabetic activity of leaf and callus extracts of Costus pictus 2012,3(6),4
- Asha S.; Deevika B.; Sadiq M.; Euphorbia hirta linn - a review on traditional uses, phytochemistry and pharmacology 2014
- Maity P.; Hansda D.; Bandyopadhyay U.; Mishra D.K.; Biological activities of crude extracts and chemical constituents of Bael, Aegle marmelos (L.) Corr. Indian J Exp Biol 2009,47(11),849-861
- Goel R, Bhatia D, Gilani SJ, et al. Medicinal plants as antidiabetics : A review. 2012. Available from: /paper/MEDICINALPLANTS- AS-ANTI-DIABETICS-%3A-A-REVIEW-Goel- Bhatia/0dba9b1fc1a0e99617ec09816eac22001535003b. (Accessed May 30, 2021)
- Atangwho I.J.; Ebong P.E.; Eyong E.U.; Comparative chemical composition of leaves of some antidiabetic medicinal plants: Azadirachta indica, Vernonia amygdalina and Gongronema latifolium. Afr J Biotechnol 2009,8(18),4685-4689
- Kumar S.; Kavimani S.; Jayaveera K.N.; A review on medicinal plants with potential antidiabetic activity 2013,253-260
- Mukhtar H.M.; Ansari S.H.; Bhat Z.A.; Naved T.; Singh P.; Antidiabetic activity of an ethanol extract obtained from the stem bark of Psidium guajava (Myrtaceae). Pharmazie 2006,61(8),725-727
- Basch E.; Ulbricht C.; Kuo G.; Szapary P.; Smith M.; Therapeutic applications of fenugreek. Altern Med Rev 2003,8(1),20-27
- Pankaj N.K.; Alam M.; Roy B.K.; Antidiabetic activity of seed powder of Holarrhena antidysenterica in rabbits. Journal of Research-Birsa Agricultural University Birsa Agricultural University 2005,17(1),95
- Simmonds MS, Howes M-JR. Plants used in the treatment of diabetes. Traditional medicines for modern time—antidiabetic plants CRC Press/Taylor and Francis Group 2006; 6: 19-82.
- Ayodhya S.; Kusum S.; Anjali S.; Hypoglycemic activity of different extracts of various herbal plants. IJRAP 2010,1,212-224
- Cantizani J.; Ortiz J.; Ravipati A.S.; Screening for natural inhibitors in Chinese medicinal plants against glycogen synthase kinase 3β (GSK-3β) 2014,205-214
- Oguntibeju O.O.; Type 2 diabetes mellitus, oxidative stress and inflammation: Examining the links. Int J Physiol Pathophysiol Pharmacol 2019,11(3),45-63
- Ibáñez-Camacho R.; Meckes-Lozoya M.; Effect of a semipurified product obtained from Opuntia streptacantha L. (a cactus) on glycemia and triglyceridemia of rabbit. Arch Invest Med (Mex) 1983,14(4),437-443
- Frati-Munari A.C.; Yever-Garcés A.; Islas-Andrade S.; Ariza-Andráca C.R.; Chávez-Negrete A.; Studies on the mechanism of “hypoglycemic” effect of nopal (Opuntia sp.). Arch Invest Med (Mex) 1987,18(1),7-12
- Al-Rowais N.A.; Herbal medicine in the treatment of diabetes mellitus. Saudi Med J 2002,23(11),1327-1331
- Varghese S.M.; Thomas J.; Polyphenolic constituents in mulberry leaf extract (M. latifolia L. cv. BC259) and its antidiabetic effect in streptozotocin induced diabetic rats. Pak J Pharm Sci 2019,32(1),69-74
- Li W.; Yuan G.; Pan Y.; Network pharmacology studies on the bioactive compounds and action mechanisms of natural products for the treatment of diabetes mellitus: A review. Frontiers in pharmacology. Frontiers (Boulder) 2017,8,74
Cited by
Microalgae Bioactives for Functional Food Innovation and Health Promotion
Guil-Guerrero, J. L., & Prates, J. A. M. (2025) · Foods · doi:10.3390/foods14122122 · Cited by 47
“…in risk factors for chronic non-communicable diseases, such as cardiovascular disease, type 2 diabetes, metabolic syndrome, cancer, and neurodegenerative disorders, has led to a surge in interest around functional foods, which are designed to deliver health benefits beyond basic nutrition [2,3].”
Metadata
- Authors
- Rahman, M. M., Islam, M. R., Rabbi, F., Islam, M. T., Sultana, S., Ahmed, M., Sehgal, A., Singh, S., Sharma, N., & Behl, T.
- Affiliations
- Daffodil International University (BD)
- Chitkara University (IN)
- Corresponding author
- Behl, Tapan
- ORCID
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2022-05
- Volume
- 28
- Issue
- 16
- Pages
- 1304-1320
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W4223904323
- Cited by
- 13
- References
- 167
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 4
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Pharmaceutical Design (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Bioactive natural compounds
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Medicinal Plant Research
- Keywords
- diabetes mellitus, bioactive compounds, antidiabetic activity, hyperglycemia, hyperlipidemia, type 1 diabetes, type 2 diabetes, phytochemicals, oral antidiabetic drugs, insulin
- MeSH terms
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bioactive Compounds and Diabetes Mellitus: Prospects and Future Challenges. https://app.cochat.ai/papers/10.2174/1381612828666220412090808
- The paper
- Rahman, M. M., Islam, M. R., Rabbi, F., Islam, M. T., Sultana, S., Ahmed, M., Sehgal, A., Singh, S., Sharma, N., & Behl, T. (2022). Bioactive Compounds and Diabetes Mellitus: Prospects and Future Challenges. Current Pharmaceutical Design. https://doi.org/10.2174/1381612828666220412090808
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.